Imidazoquinoline and tetrahydroimidazoquinoline compounds that contain
ether and urea functionality at the 1-position are useful as immune response modifiers.
The compounds and compositions of the invention can induce the biosynthesis of
various cytokines and are useful in the treatment of a variety of conditions including
viral diseases and neoplastic diseases.